| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |